03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Blastoferon 22µg : | |
Type | Medicine Authorised |
Originator | Rebif 22µg Syringes |
Agent | Droguerie Phenicia |
Distributor | Droguerie Phenicia |
Laboratory | BioSidus |
Responsible Party | BioSidus SA |
Origin | Argentina |
Manufacturer | BioSidus SA |
Manufacturing Type | G |
Origin | Argentina |
ATC | L03AB07 |
Blastoferon 22µg :
Blastoferon 22µg :
Blastoferon 22µg :
Blastoferon 22µg :
Blastoferon 22µg :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Alopecia | Common |
Anaemia | Very Common |
Anaphylactic reactions | Very rare |
Angioedema (Angioneurotic oedema) (Quincke oedema) | Rare |
Anxiety | Not known |
Arrhythmia | Not known |
Arthralgia (Pain joint) (Joint ache) | Common |
Autoantibody positive | Not known |
Autoimmune hepatitis | Rare |
Chills | Common |
Decreased appetite | Not known |
Depression | Common |
Diarrhoea (Diarrhea) | Common |
Dizziness | Not known |
Dyspnoea (dyspnea) | Uncommon |
Embolism | Uncommon |
Erythema multiforme | Rare |
Fatigue | Common |
Gait disturbance | Not known |
Glomerulosclerosis | Rare |
Haemolytic uraemic syndrome (HUS) | Rare |
Headache | Very Common |
Hepatic failure (Hepatic insufficiency) (Liver failure) | Rare |
Hepatitis | Uncommon |
Hyperthyroidism | Uncommon |
Hypoesthesia | Not known |
Hypothyroidism | Uncommon |
Influenza-like illness | Very Common |
Injection site abscess | Uncommon |
Injection site cellulitis | Rare |
Injection site infection | Uncommon |
Injection site inflammation | Very Common |
Injection site mass | Uncommon |
Injection site necrosis | Uncommon |
Injection site pain | Common |
Injection site reaction | Very Common |
Insomnia | Common |
Jaundice | Not known |
Leucopenia (Leukopenia) | Very Common |
Lupus-like syndrome | Rare |
Lymphopenia | Very Common |
Maculopapular rash | Common |
Menorrhagia | Not known |
Metrorrhagia | Not known |
Muscle spasms | Not known |
Musculoskeletal stiffness | Not known |
Myalgia | Common |
Nausea | Common |
Nephrotic syndrome | Rare |
Neurological symptom | Not known |
Neutropenia | Very Common |
Palpitations | Not known |
Pancytopenia | Rare |
Paraesthesia (paresthesia) | Not known |
Pruritus | Common |
Pyrexia | Common |
Rash erythematous | Common |
Retinal artery occlusion | Uncommon |
Retinal exudates | Uncommon |
Retinal vascular disorders | Uncommon |
Retinal vein occlusion | Uncommon |
Retinopathy | Uncommon |
Seizures | Uncommon |
Skin rash | Common |
Stevens-Johnson syndrome | Rare |
Suicide attempt | Rare |
Thrombocytopenia (Thrombopenia) | Very Common |
Thrombotic microangiopathy | Rare |
Thrombotic thrombocytopenic purpura (TTP) | Rare |
Thyroid disorder | Uncommon |
Transaminases increased | Very Common |
Urticaria | Uncommon |
Vasodilation procedure | Not known |
Vomiting | Common |
Blastoferon 22µg :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Blastoferon 22µg MoH 10868 :
Form | Solution for injection |
Packaging | Pre-filled Syringe |
Package Size | 12x0.5ml |
Strength | (6MIU) 22µg/0.5ml |
Public Price | 668001 L.L. |
Stratum | E1 |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 57217/1 |
Submission date | 25/04/2017 |
Registration Year | 24/04/2019 |
Pending Year | 18/12/2018 |
Pending Reason | Incomplete file |
Price Comparison
You have to register to view this info
You have to register to view this info
Note
You have to register to view this info
Drop File